cFLIPL Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress

Yun Zhao Li1,2,3, Hui Wu4,5,6, Di Liu1,2,3

  • 1Institute of Cardiovascular Disease, China Three Gorges University, Yichang, 443003, China.

Abstract

Insights

Cellular FLICE-inhibitory protein (cFLIP) long isoform (cFLIPL) is reduced in myocardial ischemia-reperfusion injury (MIRI), leading to endoplasmic reticulum stress (ERS) and apoptosis. Upregulating cFLIPL protects against MIRI by inhibiting ERS and p38 MAPK activation.

Area of Science:

  • Cardiovascular Biology
  • Cellular Stress Response
  • Molecular Medicine

Background:

  • Endoplasmic reticulum stress (ERS) is a key factor in myocardial ischemia-reperfusion injury (MIRI).
  • Cellular FLICE-inhibitory protein (cFLIP) regulates apoptosis and ERS.
  • The long isoform of cFLIP (cFLIPL) role in MIRI is not fully understood.

Purpose of the Study:

  • To investigate the effect of cFLIPL on apoptosis and ERS in MIRI.
  • To elucidate the underlying molecular mechanisms of cFLIPL in MIRI.

Main Methods:

  • Established MIRI models in Sprague-Dawley rats and H9c2 cells using ischemia/reperfusion (I/R) and hypoxia/reoxygenation (H/R) protocols.
  • Utilized cFLIPL recombinant adenovirus for overexpression in vivo and in vitro.
  • Assessed cardiomyocyte viability, apoptosis, ERS markers (GRP78, IRE-1, PERK), and p38 MAPK activation via coimmunoprecipitation.

Main Results:

  • cFLIPL expression was decreased in I/R and H/R injury models.
  • Overexpression of cFLIPL reduced myocardial infarction and enhanced H9c2 cell viability.
  • cFLIPL overexpression inhibited ERS and apoptosis, an effect reversed by an ERS agonist.
  • cFLIPL attenuated ERS by inhibiting p38 MAPK activation.

Conclusions:

  • cFLIPL expression is downregulated in MIRI, correlating with increased ERS and apoptosis.
  • Upregulating cFLIPL mitigates MIRI by suppressing ERS and myocardial apoptosis.
  • The protective mechanism involves the inhibition of p38 MAPK activity.
  • cFLIPL represents a potential therapeutic target for MIRI.

Related Concept Videos